Constellation Brands Tops Q2 2027 Profit Forecast With $3.74 EPS

Constellation Brands (STZ) reported Q2 2027 EPS of $3.74, beating estimates by 5.4%, with revenue of $2.63B, up 3.5% YoY. The Beer segment drove growth, with revenue up 5.0% YoY. The company raised FY 2027 EPS guidance to $11.20-$11.90. Shares rose 1.3% to $117.26. Analysts are mostly bullish, with 15 buy ratings.

Original reporting
Published Oct 7, 2026, 2:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 7, 2026, 4:15 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Constellation Brands Tops Q2 2027 Profit Forecast With $3.74 EPS — source image
Decision brief

The 30-second read

$STZBullishHigh
01

Why it matters

The earnings beat and raised guidance suggest near‑term upside, but investors should monitor cost trends and competitive dynamics.

02

Market read

The report provides fresh, material information that can influence trading decisions on STZ today.

03

What to watch

Potential headwinds from input cost inflation or regulatory changes in the alcohol sector.

Relevance 8/10Novelty 9/10Timing: pre‑market today

Background

Constellation Brands is a leading beverage alcohol company with major beer brands, reporting its Q2 2027 results.

Company-level read

Ticker impact

$STZBullishHigh confidence
Context

Constellation Brands reported Q2 2027 EPS of $3.74 beating estimates and raised FY 2027 guidance to $11.20‑$11.90.

Expected impact

likely upward pressure as investors price in the beat and higher guidance

Evidence & confidence

The beat exceeds consensus by 5.4% and guidance is above prior expectations, driving a 1.3% pre‑market rise.

Market effects

Strong beer segment performance may lift other beverage and consumer discretionary stocks.

Positive earnings from a U.S. consumer staple could boost broader U.S. market sentiment.

Limited to U.S. markets; no direct global macro effect.

Counterpoint

If guidance falls short of analyst expectations later, the stock could face a pull‑back despite the beat.

Key entities

  • Constellation Brands, Inc.

    Issuer of the earnings report.

Related articles

$STZMed

STZ Maintained by Morgan Stanley -- Price Target Lowered to $145

Morgan Stanley maintained Constellation Brands (STZ) at Equal-Weight but lowered its price target to $145 from $158, citing a cautious outlook in the competitive beverage market. GuruFocus values STZ at $172.88, suggesting a 31.5% undervaluation at its current price of $118.39, with a P/E (TTM) of 10.62x. The company's GF Score is 59/100, indicating moderate overall performance.

$STZMed

Why is Constellation Brands stock sliding today?

Constellation Brands (STZ) fell 1.1% in pre-market trading after HSBC downgraded it to Hold and cut its price target to $135. The company's Q2 2027 earnings showed mixed results, with adjusted EPS of $3.74 and net sales of $2.63B beating estimates, but beer depletions fell 0.6%. Analysts had mixed reactions, with some cutting price targets but maintaining bullish ratings, while others kept Buy ratings. The broader market downturn also contributed to the slide.